Comparison of naltrexone, 6α-naltrexol, and 6β-naltrexol in morphine-dependent and in nondependent rhesus monkeys

No abstract is available for this paper.

• Publication year

  2007

• Venue

  Psychopharmacology

• Publication date

  2007-09-16

• Fields of study

  Medicine, Chemistry

• Identifiers
  DOI 10.1007/s00213-007-0914-9
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar

• No claims are published for this paper.

• No concepts are published for this paper.

• Time-dependent decreases in apparent pA2 values for naltrexone studied in combination with morphine in rhesus monkeys

  2007cited by this paper
• Different Effects of Opioid Antagonists on μ-, δ-, and κ-Opioid Receptors with and without Agonist Pretreatment

  2007influential reference
• Differential in Vivo Potencies of Naltrexone and 6β-Naltrexol in the Monkey

  2006influential reference
• Synthesis and hydrolytic behavior of two novel tripartate codrugs of naltrexone and 6beta-naltrexol with hydroxybupropion as potential alcohol abuse and smoking cessation agents.

  2006cited by this paper
• Enhancement of transdermal delivery of 6-beta-naltrexol via a codrug linked to hydroxybupropion.

  2006cited by this paper
• Physiological relevance of constitutive activity of 5-HT2A and 5-HT2C receptors.

  2005cited by this paper
• Effect of serotonin depletion on 5-HT2A-mediated learning in the rabbit: evidence for constitutive activity of the 5-HT2A receptor in vivo

  2005cited by this paper
• In Vivo Characterization of 6β-Naltrexol, an Opioid Ligand with Less Inverse Agonist Activity Compared with Naltrexone and Naloxone in Opioid-Dependent Mice

  2005influential reference
• Opioid antagonists differ according to negative intrinsic efficacy in a mouse model of acute dependence

  2005influential reference
• Basal Signaling Activity of μ Opioid Receptor in Mouse Brain: Role in Narcotic Dependence

  2004cited by this paper
• Combating opiate dependence: a comparison among the available pharmacological options

  2004cited by this paper
• Constitutive Activity of the Serotonin2C Receptor Inhibits In Vivo Dopamine Release in the Rat Striatum and Nucleus Accumbens

  2004cited by this paper
• In vivo and in vitro potency studies of 6ß‐naltrexol, the major human metabolite of naltrexone

  2002cited by this paper
• A Mutation-induced Activated State of the ,&-Adrenergic Receptor EXTENDING THE TERNARY COMPLEX MODEL*

  2001cited by this paper
• Inverse agonists and neutral antagonists at µ opioid receptor (MOR): possible role of basal receptor signaling in narcotic dependence

  2001cited by this paper
• Pharmacologic approaches to the management of alcoholism.

  2001cited by this paper
• Effect of 5-HT2 receptor antagonists on a cranial nerve reflex in the rabbit: evidence for inverse agonism

  1999cited by this paper
• SOME QUANTITATIVE USES OF DRUG ANTAGONISTS

  1997cited by this paper
• Human herpesvirus KSHV encodes a constitutively active G-protein-coupled receptor linked to cell proliferation

  1997cited by this paper
• Secretion of Protease Nexin-1 by C6 Glioma Cells Is under the Control of a Heterotrimeric G Protein, Go1*

  1996cited by this paper
• Silencing of the Constitutive Activity of the Dopamine D1B Receptor

  1996cited by this paper
• Inverse agonism: pharmacological curiosity or potential therapeutic strategy?

  1995cited by this paper
• Accelerated communciation: Constitutive μ opioid receptor activation as a regulatory mechanism underlying narcotic tolerance and dependence

  1994cited by this paper
• A mutation-induced activated state of the beta 2-adrenergic receptor. Extending the ternary complex model.

  1993cited by this paper
• Drug efficacy at guanine nucleotide-binding regulatory protein-linked receptors: thermodynamic interpretation of negative antagonism and of receptor activity in the absence of ligand.

  1992cited by this paper
• Apparent affinity of opioid antagonists in morphine-treated rhesus monkeys discriminating between saline and naltrexone.

  1990cited by this paper
• Discriminative stimulus effects of naltrexone in morphine-treated rhesus monkeys.

  1989cited by this paper
• Bioequivalence, dose-proportionality, and pharmacokinetics of naltrexone after oral administration.

  1984cited by this paper
• pA2 and receptor differentiation: a statistical analysis of competitive antagonism.

  1979cited by this paper
• Disposition of (15,16-3H)naltrexone in the central nervous system of the rat.

  1976cited by this paper
• Metabolic reduction of naltrexone. I. Synthesis, separation and characterization of naloxone and naltrexone reduction products and qualitative assay of urine and bile following administration of naltrexone, alpha-naltrexol, or beta-naltrexol.

  1975cited by this paper

• The imidazoline I2 receptor agonist 2-BFI reduces abuse-related effects of morphine: self-administration and drug discrimination

  2023cites this paper
• Ligand-Free Signaling of G-Protein-Coupled Receptors: Relevance to μ Opioid Receptors in Analgesia and Addiction

  2022cites this paper
• Sustained opioid antagonism modulates striatal sensitivity to baby schema in opioid use disorder.

  2018cites this paper
• Therapeutic Drug Monitoring of Naltrexone and 6&bgr;-Naltrexol During Anti-craving Treatment in Alcohol Dependence: Reference Ranges

  2018cites this paper
• Long-Lasting Effects of Methocinnamox on Opioid Self-Administration in Rhesus Monkeys

  2018cites this paper
• Extended‐release naltrexone modulates brain response to drug cues in abstinent heroin‐dependent patients

  2014cites this paper
• Antihyperalgesic effects of imidazoline I2 receptor ligands in rat models of inflammatory and neuropathic pain

  2014cites this paper
• Impulsivity and drugs of abuse: a juice-reinforced operant procedure for determining within-session delay discounting functions in rhesus monkeys.

  2012cites this paper
• Drug Discrimination Studies in Rhesus Monkeys: Drug Dependence and Withdrawal

  2011cites this paper
• The Effects of 6β-Naltrexol, a Putative Neutral Opioid Antagonist, in Opioid-Dependent Subjects: A Proof-of-Concept Trial

  2011cites this paper
• Relative potency of the opioid antagonists naloxone and 6-alpha-naloxol to precipitate withdrawal from acute morphine dependence varies with time post-antagonist.

  2009cites this paper
• Shadows across μ‐Star? Constitutively active μ‐opioid receptors revisited

  2009cites this paper
• The Relative Potency of Inverse Opioid Agonists and a Neutral Opioid Antagonist in Precipitated Withdrawal and Antagonism of Analgesia and Toxicity

  2009cites this paper
• Endogenous opiates and behavior: 2008.

  2009cites this paper
• Interactions between Δ9-tetrahydrocannabinol and μ opioid receptor agonists in rhesus monkeys: discrimination and antinociception

  2008cites this paper